Fungi are ubiquitous in the biosphere with an estimate of around two to five million species (Blackwell 2011; Hawksworth and Lucking 2017) . This diverse group of organisms occupies most, if not all, environmental niches and plays many roles vital to our daily life (see the 2018 State of the World's Fungi report for interesting fungal facts -https://stateoftheworldsfungi.org). One indispensable role of fungi is their contribution to the ecosystem; they are crucial in decomposing complex carbon compounds, recycling nutrients, and facilitating nutrient exchanges between organisms (Mohan et al. 2014; Treseder and Lennon 2015) . There is a long history of fungi used in food production (e.g., fermentation), and some of them can be taken directly as food for nutritional or medicinal purposes (Dupont et al. 2017) . Fungi are also renowned for their drug potentials with the most famous example being the antibiotic penicillin that has saved countless lives since its discovery. Analysis of hundreds of fungal genome sequences indicates a large repertoire of novel secondary metabolites waiting to be discovered for therapeutic uses (Khaldi et al. 2010; de Vries et al. 2017) . Moreover, certain fungi are also employed by the Biotech industry as Bfactories^for drugs, enzymes, and biofuel production (Baker 2013; Buijs et al. 2013; Money 2016; Cairns et al. 2018) .
Fungi also have their dark side. Fungal pathogens pose increasing threats to plants and animals including humans (Fisher et al. 2012) . Mild superficial fungal infections of humans are very common, but more importantly, lifethreatening systemic fungal infections have risen over the past decade as a result of increasing application of immunosuppressive therapy for various diseases. In fact, preventing and treating fungal diseases have become a major clinical challenge. Similarly, plant fungal pathogens have always been a big problem in agriculture; e.g., fungal infections of food crops not only reduce yields but can also cause mycotoxin contamination that may have adverse effects on humans such as the cancer-causing aflatoxin (Gruber-Dorninger et al. 2017) .
Growth and metabolic flexibility and ability to quickly sense, respond, and adapt to constantly changing environments are essential for the success of fungi in colonizing almost any environments. For example, human fungal pathogens need to adapt to the host body temperature as well as to respond and overcome attacks from the immune system during infection (Braunsdorf et al. 2016; Köhler et al. 2017) . Similarly, saprophytic fungi have to constantly compete with other microbes for limiting nutrients in harsh environments. Therefore, most fungal physiological processes and responses must be highly dynamic.
Transcription is the first essential step in retrieving genome information for all biological processes. It is expected that genes required (or detrimental) for growth and survival of fungi (in fact all organisms) under a specific condition must be tightly regulated in response to constantly changing environments in order to maintain cellular homeostasis. As such, knowing what and when genes are expressed under particular conditions of interest can reveal the physiological pathways necessary for fungi to survive and grow under that condition. Microarray and RNA-seq are two commonly used methods for determining genome-wide gene expression. These methods are based on calculating the steady-state mRNA level, which is a composite measure of both mRNA synthesis and mRNA degradation rates. While useful for estimating gene expression, they cannot reliably reflect the actual level of transcription activities and are not suitable for mapping dynamic transcription responses, especially over very short time scales. This is due to the fact that mRNA degradation rate can differ between genes and even among transcript isoforms of the same gene (Geisberg et al. 2014; Gupta et al. 2014 ) and that mRNA stability may also vary between different physiological conditions (Maekawa et al. 2015; Miller et al. 2018 ). These would then affect steady-state mRNAs levels. Therefore, the classical profiling methods like microarray and RNA-seq have apparent shortcomings in studying fungal transcriptional responses.
ChIP-seq can map genome-wide active and dynamic transcription responses
Chromatin immuno-precipitation (ChIP) measures in vivo association of proteins with chromatin. It involves crosslinking (usually by formaldehyde) of proteins to chromatin, followed by pulling down a protein-of-interest (e.g., transcription factor) along with any associated DNA using either a proteinspecific antibody or an epitope-specific antibody if the protein-of-interest is tagged with an epitope. The level of protein occupancy on DNA can be measured by a number of downstream methods. For a small number of known or candidate targets, the pulled-down DNAs can be quantified by PCR or real-time PCR. Alternatively, microarray (ChIP) or next generation sequencing (seq) may be applied for mapping protein occupancy at the genome-wide level as well as for identifying unknown targets bound by the protein-of-interest. ChIP, ChIP-chip, and ChIP-seq have been extensively applied to studying various biological processes that happen on chromatin (e.g., transcription, chromatin remodeling, and DNA repair) and are arguably the most powerful techniques in the transcription and chromatin field.
Using ChIP-chip or ChIP-seq against RNA polymerase II (PolII), actively transcribing genes, can be mapped and the transcription level of each gene can be measured simply by quantifying PolII occupancy (e.g., the amount of DNA pulled down by PolII) on the gene (Fig. 1) . As with RNA-seq, PolII ChIP-seq/ChIP-chip readouts are also quantitative measurements of gene expression, although they are somewhat less accurate for genes that are subjected to transcript stability controls. Importantly, as formaldehyde crosslinking is instantaneous, transcription levels determined by PolII ChIP-seq present a snapshot of active transcription events occurring at the time of crosslinking. This feature has made the ChIP-based technique extremely powerful in capturing dynamic transcription responses in time-course experiments with timescales as short as a few minutes (Mason and Struhl 2005; Proft et al. 2006; Wong and Struhl 2011; Wong et al. 2014) . Such high temporal resolution cannot be achieved by methods relying on steady-state mRNA levels.
Commercial antibodies specific to the highly conserved C-terminal domain of PolII are available and can be used for fungi Availability, specificity, and affinity of antibodies to proteinsof-interest not only dictate whether ChIP/ChIP-seq assays can be applied but also govern whether a ChIP experiment would be successful and determine data quality. The C-terminal domain (CTD) of the largest subunit of the PolII complex is highly conserved among eukaryotes and is present in all eukaryotic PolII, differing mainly in the numbers of heptad repeats (e.g., YSPTSPS) between different species (Eick and Geyer 2013; Yang and Stiller 2014) . For example, Saccharomyces cerevisiae and human PolII have 26 and 52 heptad repeats, respectively, with many of the repeats being Fig. 1 Genome-browser view of PolII ChIP-seq data. PolII ChIPseq can be used to profile genome-wide transcription activities by measuring PolII occupancies (e.g., ChIP-seq signals) over gene bodies. This powerful genome-wide transcription profiling method can capture active transcription events and global dynamic transcription changes in time-course experiments identical although minor sequence variation is observed for some heptads. Because of this, antibodies specific for heptad repeats (e.g., 8WG16) or their post-translationally modified forms (e.g., 3E8 and 3E10) can be used to immunoprecipitate PolII from different eukaryotic species. Some of these antibodies are commercially available and have been extensively used in PolII ChIP and ChIP-seq experiments of various organisms from humans to worms, flies, as well as fungi (e.g., S. cerevisiae, Schizosaccharomyces pombe, Candida albicans, and Aspergillus nidulans).
PolII ChIP-seq is much more affordable than RNA-seq
The advent of next generation sequencing has opened up genome-wide profiling studies to any organisms, but experimental cost is still a major consideration. It is noteworthy that a number of unique features of fungal genomes have rendered genome-wide profiling experiments relatively less expensive for fungi as compared to higher eukaryotes. First, fungal genomes are very compact with around 6000-15,000 genes arranged within genomes of~10-30 Mb in size on average. Second, the majority of genes are relatively short (e.g., around 1-2 kb), as compared to genes in higher eukaryotes. Third, unlike in humans, fungal introns are usually small with respect to exons, and certain species such as S. cerevisiae do not even have introns for most genes (Goffeau et al. 1996; Stajich et al. 2007; Hooks et al. 2014) .
Although these genomic features equally apply to both RNA-seq and PolII ChIP-seq, PolII ChIP-seq has an additional and rather significant cost advantage in that PolII ChIP-seq only captures active transcription events (i.e., genes/DNA regions with elongating PolII), while RNA-seq measures total steady-state mRNAs that include stable mRNAs from previous transcription events. For example, most genes have some level of mRNA detected in RNA-seq experiments, while analysis of a significant number of fungal PolII ChIP-seq data reveals that in general, only about 10% of genes are actually engaged in the transcription process at a given time and condition. Therefore, far fewer sequencing reads are actually needed for a genome-wide transcription profile by PolII ChIP-seq as compared to RNA-seq. This provides a significant cost saving advantage for PolII Chipseq. Based on our experience, when using similar amounts of fungal cells or biomass as starting materials, around two to three millions raw reads from the Illumina platform are sufficient for highquality PolII ChIP-seq profiles for fungi (e.g., S. cerevisiae, C. albicans, and A. nidulans), while standard RNA-seq datasets typically require~20 to 30 million raw reads (assuming a mapping rate of about 80%). In other words, the sequencing cost for transcription profiles using PolII ChIP-seq is at least ten times cheaper than by RNA-seq.
In addition, experimental cost for a PolII ChIP-seq experiment (antibody, DNA detection and purification reagents, ChIP-seq library preparation kit, etc.) is only approximately half of that for a standard RNA-seq pipeline (RNA extraction, RNA quality assessment, mRNA purification or enrichment, RNA-seq library preparation, etc.). Currently, the overall cost for one PolII ChIP-seq profile generated using a multiplexing system (Wong et al. 2013 ) is around USD 50-60. At this cost, ChIP DNA detection through sequencing is actually much more cost-effective than by real-time PCR, because the amount is merely sufficient for quantifying a handful of genes using real-time PCR as opposed to genome-wide information by sequencing. This already extremely affordable cost is expected to further reduce as NGS technology improves and sequencing costs continues to drop. Therefore, global transcription profiling by PolII ChIP-seq is likely to become a routine method in fungal studies.
Concluding remarks
With the advent of NGS, genome-wide transcription profiling can now be readily performed for any organism. RNA-seq is a powerful method and often is the method-of-choice for global gene expression studies, but it has shortcomings in studying fungal physiologies and transcriptional responses that are rapid and highly dynamic. To this end, the ability to map active transcription changes over short temporal time scales and highly affordable experimental cost render PolII ChIP-seq a more attractive profiling method for fungi (and in fact, also for other organisms, especially those with a small genome size). It has been proven useful in understanding various key fungal functions (Leach et al. 2016; Xie et al. 2017; Veri et al. 2018 ), and we believe that PolII ChIP-seq is a powerful approach for studying this group of fascinating organisms.
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